Carlotta Raschioni
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: February 23, 2018
CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression.
Journal: Disease markers
Published: September 28, 2017
Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer.
Journal: International journal of molecular sciences
Published: December 08, 2016
An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.
Journal: Breast cancer research : BCR
Published: April 28, 2016
Targeting microRNAs as key modulators of tumor immune response.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 07, 2016
AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients.
Journal: NPJ breast cancer
Published: April 05, 2016
TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: February 25, 2015
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study.
Journal: Clinical colorectal cancer
Published: December 05, 2014
YAP activation is an early event and a potential therapeutic target in liver cancer development.
Journal: Journal of hepatology
Published: April 20, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026